These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E. Akush Ginekol (Sofiia); 2016 Sep; 55(4):20-29. PubMed ID: 29370489 [Abstract] [Full Text] [Related]
11. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans. Liao H, Liu S, Wang H, Su H, Liu Z. Pathog Dis; 2017 Aug 31; 75(6):. PubMed ID: 28645176 [Abstract] [Full Text] [Related]
19. Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy. Crouss T, Sobel JD, Smith K, Nyirjesy P. J Low Genit Tract Dis; 2018 Oct 31; 22(4):382-386. PubMed ID: 29975334 [Abstract] [Full Text] [Related]
20. Vulvovaginal candidiasis in a Flemish patient population. De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ. Clin Microbiol Infect; 2005 Dec 31; 11(12):1005-11. PubMed ID: 16307555 [Abstract] [Full Text] [Related] Page: [Next] [New Search]